COVID-19

Last February, when more than 100 Biogen representatives from around the world attended a conference, they unwittingly became a means for SARS-CoV-2 virus to spread. As they and their contacts became sick, Biogen asked those people to contribute blood samples to the Broad Institute, and about 30 people agreed, with another 120 yet to be drawn. Among other things so far, this biobank cohort has shown that “people infected with SARS-CoV-2 produce antibodies in response, but only a subset of those people produce antibodies capable of neutralizing the virus . . . . A question out there is, do patients make high-titer neutralizing antibodies following a mild infection, or is it less common than after a severe infection that requires hospitalization?”     MORE

Image Credit:  pxhere.com